1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
4[1]Peck K, Sher YP, Shih JY, et al. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients[J]. Cancer Res, 1998, 58(13) :2761 被引量：1
5[2]Funaki NO, Tanaka J, Ohshio G, et al. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients[J]. Br J Cancer. 1998, 77(8) :1327 被引量：1
6[3]Banchereau J, Steinman R. Dendritic cells and the control of immunity[J]. Nature, 1998, 392:245 被引量：1
7[4]Avigan D. Dendritic cells: development, function and potential use for cancer immunotherapy[J]. Blood Rev, 1999,13(1):51 被引量：1
8[5]Schmidt-Wolf I, Negrin R, Kiem H, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[J3. J Exp Med,1991, 174:139 被引量：1
9[6]Marten A, Ziske C, Schottker B, et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations[J]. J Immunol, 2001, 24(6) :502 被引量：1
10[7]Marten A, Schottker B, Ziske C, et al. Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein[J]. J Immunol, 2000, 23(4):464 被引量：1
1Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量：83
4Robnson E, Segal R, Stumnger L, et al. Lymphocyte subpopullatione in patients with multiple primary tumor [ J]. Cancer, 1999, 85 (9) :2073 - 2076. 被引量：1
5Bac DJ, Spplinter TAW, Kok TC, et al. Evaluation of CA19 -9 serum levels of monitoring disease activity during chemotherapy of pancreatic ad 117:263. [J]. Cancer Res Clin Oncol, 1991. 被引量：1
6Schott M, Seisslar J. Dendritic cell vaccination : new hope for the treatment of metastasized endocrime malignancies [ J ]. Trends Endocrinal Metab, 2003, 14(4) :156 - 162. 被引量：1
7Friedl J, Stift A, Paolini P . Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human heptocelluluar [ J ]. Cancer Biother Radiopharm,2000,15(5):477-486. 被引量：1
8Yeb C Linn, Siew Kee J Lau, Bee H Liu, et al. Characterization of the recognition and functional heterogeneity exhibited by eytokine - induced killer cell subsets against acute myeloid leukaemia targetcell [J]. Immunology, 2009, 26(3) :423 -435. 被引量：1
9Leemhuis T, Wells S, Scheffold C ,et al . A phase I trial of outologous cytokine - induced killer ceils for the treatment of relapsed Hodgkin disease and non - Hodgkin lymphoma [ J ]. Biol Blood Marrow Transplant, 2005, 11 (3) : 181 - 187. 被引量：1
10Schmidt - Wolf IG, Finke S, Trojaneck B, et al. Phase I clinical study applying autologous immunological effector ceils transfected with the interleukin -2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma [ J ]. Br j Cancer, 1999, 81 (6) :1009 - 1016. 被引量：1
